Literature DB >> 26740275

Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan.

Jemiina Salo1, Annukka Pietikäinen1, Mirva Söderström2, Kaisa Auvinen3, Marko Salmi3, Rhodaba Ebady4, Tara J Moriarty4, Matti K Viljanen5, Jukka Hytönen5.   

Abstract

BACKGROUND: Bacterial pathogens causing systemic infections disseminate from the initial infection focus to the target organs usually through the blood vasculature. To be able to colonize various organs, bacteria need to adhere to the endothelial cells of the vascular wall, and the adhesion must be strong enough to resist the shear force of the blood flow.Borrelia burgdorferi sensu lato spirochetes, the causative agents of the tick-borne disease Lyme borreliosis, disseminate hematogenously from the tick bite site to the joints, the heart, and the central nervous system of the patient.
METHODS: We used both wild-type and genetically modified B. burgdorferi s. l. bacteria, recombinant borrelia adhesins, and an array of adhesion assays carried out both under stationary and flow conditions to investigate the molecular mechanisms of borrelial adhesion to human endothelial cells.
RESULTS: Borrelia garinii, a member of the B. burgdorferi s. l. complex, adhered to biglycan expressed by human endothelial cells in a flow-tolerant manner. The adhesion was mediated by the decorin-binding protein A (DbpA) and DbpB surface molecules of B. garinii.
CONCLUSIONS: The proteoglycan biglycan is a receptor molecule for flow-resistant adhesion of the bacterial pathogen B. garinii on human endothelial cells.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  DbpA; DbpB; HUVEC; adhesion; biglycan; borrelia

Mesh:

Substances:

Year:  2016        PMID: 26740275     DOI: 10.1093/infdis/jiw003

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.

Authors:  Yi-Pin Lin; Lingyun Li; Fuming Zhang; Robert J Linhardt
Journal:  Microbiology       Date:  2017-11-08       Impact factor: 2.777

2.  Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.

Authors:  Yi-Pin Lin; Yanlei Yu; Ashley L Marcinkiewicz; Patricia Lederman; Thomas M Hart; Fuming Zhang; Robert J Linhardt
Journal:  ACS Infect Dis       Date:  2020-01-30       Impact factor: 5.084

Review 3.  Live Imaging.

Authors:  George Chaconas; Tara J Moriarty; Jon Skare; Jenny A Hyde
Journal:  Curr Issues Mol Biol       Date:  2020-12-12       Impact factor: 2.081

4.  Identification of Tp0751 (Pallilysin) as a Treponema pallidum Vascular Adhesin by Heterologous Expression in the Lyme disease Spirochete.

Authors:  Wei-Chien Andrew Kao; Helena Pětrošová; Rhodaba Ebady; Karen V Lithgow; Pablo Rojas; Yang Zhang; Yae-Eun Kim; Yae-Ram Kim; Tanya Odisho; Nupur Gupta; Annette Moter; Caroline E Cameron; Tara J Moriarty
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

Review 5.  Borrelia burgdorferi Keeps Moving and Carries on: A Review of Borrelial Dissemination and Invasion.

Authors:  Jenny A Hyde
Journal:  Front Immunol       Date:  2017-02-21       Impact factor: 7.561

6.  Actinobacillus pleuropneumoniae Interaction With Swine Endothelial Cells.

Authors:  Berenice Plasencia-Muñoz; Francisco J Avelar-González; Mireya De la Garza; Mario Jacques; Adriana Moreno-Flores; Alma L Guerrero-Barrera
Journal:  Front Vet Sci       Date:  2020-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.